Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 3 1Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Myelodysplastic Syndromes 11Multiple Myeloma 11Lymphoma, Non-Hodgkin 11Hodgkin Disease 11Leukemia, Lymphocytic, Chronic, B-Cell 9Hematologic Neoplasms 9Myeloproliferative Disorders 8Leukemia, Myelomonocytic, Chronic 8Lymphoma, Mantle-Cell 7Leukemia 7Lymphoma, Follicular 6Lymphoma 6Lymphoma, B-Cell, Marginal Zone 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Leukemia, Biphenotypic, Acute 5Waldenstrom Macroglobulinemia 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Myeloid, Accelerated Phase 4Carcinoma, Renal Cell 4Burkitt Lymphoma 4Anemia, Refractory, with Excess of Blasts 4Anemia, Aplastic 4Lymphoma, T-Cell, Cutaneous 3Lymphoma, Large-Cell, Immunoblastic 3Leukemia, Myeloid, Chronic-Phase 3Congenital Abnormalities 3Blast Crisis 3Thrombocythemia, Essential 2

Interventions

Methotrexate 5Peripheral Blood Stem Cell Transplantation 4Cyclosporine 4Busulfan 4Cyclophosphamide 3Azacitidine 3ruxolitinib 2fludarabine phosphate 2Tacrolimus 2Mycophenolic Acid 2Injections 2Filgrastim 2Decitabine 2Alemtuzumab 2venetoclax 1tagraxofusp 1posaconazole 1gilteritinib 1flt3 ligand protein 1ethanolamine oleate 1axatilimab 1Whole-Body Irradiation 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Thrombopoietin 1Sulfamethoxazole 1Stem Cell Factor 1Specimen Handling 1Sodium Chloride 1Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Myelodysplastic-Myeloproliferative Diseases × Whole-Body Irradiation × Clear all
NCT00245037 2017-09-27

Bu Flu TBI

OHSU Knight Cancer Institute

Phase 1/2 Completed
147 enrolled 19 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Precancerous Conditions, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡